M&T Bank Corp Has $2.70 Million Position in Agilent Technologies, Inc. (NYSE:A)

M&T Bank Corp lowered its position in Agilent Technologies, Inc. (NYSE:A) by 9.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,119 shares of the medical research company’s stock after selling 2,402 shares during the quarter. M&T Bank Corp’s holdings in Agilent Technologies were worth $2,704,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. Redwood Park Advisors LLC acquired a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $27,000. Lee Danner & Bass Inc. acquired a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $29,000. Sunbelt Securities Inc. increased its position in Agilent Technologies by 640.0% during the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 192 shares during the period. Whipplewood Advisors LLC increased its position in Agilent Technologies by 286.2% during the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company’s stock valued at $29,000 after purchasing an additional 186 shares during the period. Finally, Wood Tarver Financial Group LLC acquired a new stake in Agilent Technologies during the 4th quarter valued at approximately $34,000.

Analyst Ratings Changes

A number of research firms have weighed in on A. Evercore ISI increased their target price on shares of Agilent Technologies from $125.00 to $130.00 and gave the company an “in-line” rating in a research report on Tuesday. Leerink Partners increased their target price on shares of Agilent Technologies to $135.00 and gave the company a “buy” rating in a research report on Friday, May 30th. JPMorgan Chase & Co. cut their price target on Agilent Technologies from $160.00 to $155.00 and set an “overweight” rating on the stock in a report on Thursday, May 29th. TD Cowen increased their price target on Agilent Technologies to $150.00 and gave the stock a “buy” rating in a report on Thursday, May 29th. Finally, Barclays increased their price target on Agilent Technologies from $115.00 to $125.00 and gave the stock an “equal weight” rating in a report on Tuesday, June 24th. Six analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $139.77.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of Agilent Technologies stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total transaction of $177,099.52. Following the transaction, the chief executive officer directly owned 37,448 shares of the company’s stock, valued at $4,397,893.12. The trade was a 3.87% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Agilent Technologies Stock Performance

NYSE A opened at $123.35 on Friday. The company has a fifty day simple moving average of $115.23 and a 200 day simple moving average of $122.85. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55. The company has a market cap of $35.04 billion, a P/E ratio of 30.46, a PEG ratio of 3.77 and a beta of 1.23.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.05. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.63 billion. During the same quarter last year, the firm posted $1.22 EPS. Agilent Technologies’s revenue was up 6.0% compared to the same quarter last year. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st will be issued a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.80%. The ex-dividend date of this dividend is Tuesday, July 1st. Agilent Technologies’s dividend payout ratio is 24.44%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.